Literature DB >> 7489838

Methodological aspects, dose-response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects.

T Utriainen1, R Malmström, S Mäkimattila, H Yki-Järvinen.   

Abstract

To resolve some of the controversy regarding insulin regulation of blood flow, we performed in 20 normal subjects a) a reproducibility study of plethysmographic, Doppler ultrasound and laser Doppler blood flow measurements (n = 7), b) a sequential insulin dose-response study with measurement of forearm (plethysmography), leg (Doppler ultrasound) and skin (laser Doppler) blood flow (n = 12), and c) a sequential insulin dose-response study with comparison of forearm (plethysmography) and calf (plethysmography) blood flow (n = 8). We also searched for factors which might explain the interindividual variation in the blood flow response to insulin. During sequential insulin infusions (2 h each, 61 +/- 2, 139 +/- 6, 462 +/- 15 mU/l), forearm blood flow increased by 17 +/- 6, 50 +/- 14 and 113 +/- 17% (p < 0.05 or less between steps), respectively. The increase at the 61 +/- 2 mU/l insulin concentration barely exceeded methodological variation (13 +/- 2%). In contrast to the continuous increase in blood flow, the glucose arterio venous difference reached its maximum (1.7 +/- 0.2 mmol/l) at the lowest 61 +/- 2 mU/l insulin concentration and remained constant thereafter. Forearm and calf blood flow responses to insulin were virtually identical when determined with plethysmography. In contrast, only a 27% increase was detected in femoral flow index as determined by Doppler ultrasound. Forearm blood flow (per forearm volume) was highly correlated with the relative forearm muscle content (mean 59 +/- 5%, range 24-81%) both basally (r = 0.86, p < 0.001, n = 12) and at all insulin concentrations (r = 0.85-0.92, p < 0.001) indicating that the percent of forearm that is muscle explains 70-85% of interindividual variation in blood flow. In conclusion 1) physiological insulin concentrations stimulate glucose uptake mainly by increasing glucose extraction while supraphysiological insulin concentrations increase forearm glucose uptake predominantly via increases in blood flow. 2) The dose-response characteristics of insulin stimulation of forearm and calf blood flow are similar when determined with strain-gauge plethysmography. 3) Relative forearm muscle content is a key factor in determining both basal forearm blood flow and the interindividual variation in its response to insulin in normal subjects.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7489838     DOI: 10.1007/bf00400724

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  34 in total

1.  THEORY OF THE USE OF ARTERIOVENOUS CONCENTRATION DIFFERENCES FOR MEASURING METABOLISM IN STEADY AND NON-STEADY STATES.

Authors:  K L Zierler
Journal:  J Clin Invest       Date:  1961-12       Impact factor: 14.808

2.  Effects of insulin on skeletal muscle glucose storage, oxidation, and glycolysis in humans.

Authors:  D E Kelley; J P Reilly; T Veneman; L J Mandarino
Journal:  Am J Physiol       Date:  1990-06

3.  Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans.

Authors:  P Vollenweider; L Tappy; D Randin; P Schneiter; E Jéquier; P Nicod; U Scherrer
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

4.  Effects of body composition on insulin sensitivity.

Authors:  H Yki-Järvinen; V A Koivisto
Journal:  Diabetes       Date:  1983-10       Impact factor: 9.461

5.  The relative proportions of fat, muscle and bone in the normal human forearm as determined by computed tomography.

Authors:  R J Maughan; J S Watson; J Weir
Journal:  Clin Sci (Lond)       Date:  1984-06       Impact factor: 6.124

6.  Euglycemic hyperinsulinemia augments amino acid uptake by human leg tissues during hyperaminoacidemia.

Authors:  W M Bennet; A A Connacher; C M Scrimgeour; R T Jung; M J Rennie
Journal:  Am J Physiol       Date:  1990-08

7.  Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance.

Authors:  M Laakso; S V Edelman; G Brechtel; A D Baron
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

8.  Insulin differentially regulates systemic and skeletal muscle vascular resistance.

Authors:  A D Baron; G Brechtel
Journal:  Am J Physiol       Date:  1993-07

9.  Skeletal muscle blood flow independently modulates insulin-mediated glucose uptake.

Authors:  A D Baron; H Steinberg; G Brechtel; A Johnson
Journal:  Am J Physiol       Date:  1994-02

10.  The influence of graded hyperglycemia with and without physiological hyperinsulinemia on forearm glucose uptake and other metabolic responses in man.

Authors:  R A Jackson; J B Hamling; P M Blix; B M Sim; M I Hawa; J B Jaspan; J Belin; J D Nabarro
Journal:  J Clin Endocrinol Metab       Date:  1986-09       Impact factor: 5.958

View more
  17 in total

1.  Intact insulin stimulation of skeletal muscle blood flow, its heterogeneity and redistribution, but not of glucose uptake in non-insulin-dependent diabetes mellitus.

Authors:  T Utriainen; P Nuutila; T Takala; P Vicini; U Ruotsalainen; T Rönnemaa; T Tolvanen; M Raitakari; M Haaparanta; O Kirvelä; C Cobelli; H Yki-Järvinen
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

2.  Myocardial insulin resistance in patients with syndrome X.

Authors:  H E Botker; N Moller; O Schmitz; J P Bagger; T T Nielsen
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

Review 3.  Role of insulin resistance in the pathogenesis of NIDDM.

Authors:  H Yki-Järvinen
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

4.  Seven days of aerobic exercise training improves conduit artery blood flow following glucose ingestion in patients with type 2 diabetes.

Authors:  Catherine R Mikus; Seth T Fairfax; Jessica L Libla; Leryn J Boyle; Lauro C Vianna; Douglas J Oberlin; Grace M Uptergrove; Shekhar H Deo; Areum Kim; Jill A Kanaley; Paul J Fadel; John P Thyfault
Journal:  J Appl Physiol (1985)       Date:  2011-07-07

5.  Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity.

Authors:  H Laine; H Yki-Jarvinen; O Kirvela; T Tolvanen; M Raitakari; O Solin; M Haaparanta; J Knuuti; P Nuutila
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

6.  Sustained hyperglycaemia increases muscle blood flow but does not affect sympathetic activity in resting humans.

Authors:  P J van Gurp; G A Rongen; J W M Lenders; A K M Al Nabawy; H J L M Timmers; C J Tack
Journal:  Eur J Appl Physiol       Date:  2004-11-25       Impact factor: 3.078

7.  The response of muscle protein anabolism to combined hyperaminoacidemia and glucose-induced hyperinsulinemia is impaired in the elderly.

Authors:  E Volpi; B Mittendorfer; B B Rasmussen; R R Wolfe
Journal:  J Clin Endocrinol Metab       Date:  2000-12       Impact factor: 5.958

8.  Metoprolol compared to carvedilol deteriorates insulin-stimulated endothelial function in patients with type 2 diabetes - a randomized study.

Authors:  Britt Kveiborg; Thomas S Hermann; Atheline Major-Pedersen; Buris Christiansen; Christian Rask-Madsen; Jakob Raunsø; Lars Køber; Christian Torp-Pedersen; Helena Dominguez
Journal:  Cardiovasc Diabetol       Date:  2010-05-25       Impact factor: 9.951

9.  Obesity blunts microvascular recruitment in human forearm muscle after a mixed meal.

Authors:  Michelle A Keske; Lucy H Clerk; Wendie J Price; Linda A Jahn; Eugene J Barrett
Journal:  Diabetes Care       Date:  2009-06-01       Impact factor: 19.112

10.  Glucose levels at the site of subcutaneous insulin administration and their relationship to plasma levels.

Authors:  Stefan Lindpointner; Stefan Korsatko; Gerd Köhler; Hans Köhler; Roland Schaller; Lukas Schaupp; Martin Ellmerer; Thomas R Pieber; Werner Regittnig
Journal:  Diabetes Care       Date:  2010-01-22       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.